5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.

Authors

Apar Gupta
Atif J. Khan
Nikhil Yegya-Raman
Mutlay Sayan
Stuti Ahlawat
Nisha Ohri
Sharad Goyal, George Washington University
Dirk F. Moore
Firas Eladoumikdachi
Deborah Toppmeyer
Bruce G. Haffty

Document Type

Journal Article

Publication Date

10-1-2019

Journal

International Journal of Radiation Oncology-Biology-Physics

Volume

105

Issue

2

Inclusive Pages

267-271

DOI

10.1016/j.ijrobp.2019.05.063

Keywords

Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Intraductal, Noninfiltrating; Chemotherapy, Adjuvant; Confidence Intervals; Female; Humans; Linear Models; Lymphatic Irradiation; Middle Aged; Patient Reported Outcome Measures; Prospective Studies; Radiation Dose Hypofractionation; Radiodermatitis; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; Re-Irradiation; Time Factors; Treatment Outcome; Triple Negative Breast Neoplasms

Comments

Epub 2019 Jun 5

APA Citation

Gupta, A., Khan, A. J., Yegya-Raman, N., Sayan, M., Ahlawat, S., Ohri, N., Goyal, S., Moore, D. F., Eladoumikdachi, F., Toppmeyer, D., & Haffty, B. G. (2019). 5-Year Results of a Prospective Phase 2 Trial Evaluating 3-Week Hypofractionated Whole Breast Radiation Therapy Inclusive of a Sequential Boost.. International Journal of Radiation Oncology-Biology-Physics, 105 (2). http://dx.doi.org/10.1016/j.ijrobp.2019.05.063

Peer Reviewed

1